Cost-effectiveness analysis of endovascular therapy for unruptured brain aneurysms: Health economics evaluation and clinical outcomes as a result of using innovative medical devices

Cost-effectiveness analysis of endovascular therapy for unruptured brain aneurysms: Health economics evaluation and clinical outcomes as a result of using innovative medical devices - Cost-effectiveness analysis of endovascular therapy for unruptured brain aneurysms: Health economics evaluation and clinical outcomes as a result of using innovative medical devices

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000036508

Enrollment

Registered

2019-06-01

Start date

2019-06-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Unruptured brain aneurysms

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Subject with unruptured aneurysm who underwent endovascular therapy using the flow diverter stent in accordance with the guideline published by the Japan Neurosurgical Society and site indication as a standard of care

Exclusion criteria

Exclusion criteria: Subject with ruptured aneurysm

Design outcomes

Primary

Measure	Time frame
3 months total healthcare expenditures including initial endovascular therapy	—

Countries

Japan

Contacts

Public ContactWataro Tsuruta

Toranomon Hospital Department of Endovascular Neurosurgery

wataro@cf6.so-net.ne.jp03-3588-1111

Outcome results